294 results
Page 2 of 15
8-K
EX-10.3
889s6
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.4
jgecb
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.2
ua2sb1
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.5
j346tk yxrmluit
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.3
azz55w nqfuq
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.6
fi12wwu
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
ceanew7 s2u
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.4
35l412q8tts6f0m2vgdx
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.2
rovvz6
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
3b62ro zzykz4wceb
13 Sep 23
Entry into a Material Definitive Agreement
9:01am
8-K/A
EX-10.1
trb r15ua10y9yz
6 Sep 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
ts3x189f9kzh9 uxp6m
17 Aug 23
ABVC Executes Cooperation Agreement for Strategic Investments
8:33am
8-K
EX-10.1
7rtdsee2ud
2 Aug 23
ABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M and Royalties of 5-12% of Net Sales
5:00pm
8-K
EX-10.1
di1v0 uvrg
27 Jul 23
Entry into a Material Definitive Agreement
9:14am
8-K
EX-10.1
p54iu wc4
23 Jun 23
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.10
z0f55
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
EX-10.1
do3yc873 beu
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm